EUVC Summit 2026: The Curated GP + LP Gathering That Actually Moves Commitments
EUVC Summit & Awards on April 22 in London is one of the few EU events where LP allocations and GP relationships genuinely progress.
Venture Capital News, Guides & Fund Directory
Venture capital fuels the companies that reshape industries — from AI infrastructure and fintech to healthcare and defense tech. This hub collects our latest analysis on how VC firms evaluate startups, structure deals, and deploy capital across stages and geographies.
What You'll Find Here
- Fund profiles & directories: Stage focus, sector thesis, and check-size context for active investors
- Deal flow analysis: Funding roundups, mega-rounds, and emerging-manager activity
- Founder playbooks: Pitch decks, term sheets, warm intros, and fundraising strategy
- Market intelligence: Sector trends, valuation shifts, and LP allocation patterns
Browse the articles below to research investors, understand deal dynamics, and build a sharper fundraising strategy.
Related Articles (594 articles)
-
-
Imaginary Ventures Leads Sweet Chemistry and Alec’s Ice Cream
Imaginary Ventures led a $1.5M seed in bioactive skincare startup Sweet Chemistry and an $11M Series A for regenerative-dairy brand Alec’s Ice Cream.
-
0100 Europe 2026: The Private Markets Event Where LP Checks Actually Get Discussed
The 0100 Europe gathering on April 21–23 remains one of Europe's most pragmatic venues for GP-LP relationships and private markets deal talk.
-
NYC Early-Stage Venture in 2026: Who's Writing Seed Checks Today
A pragmatic 2026 map of NYC's most active seed and pre-seed investors — and what they actually fund.
-
Slush 2026 Preview: Helsinki's November Summit Is Still Europe's Single Biggest VC Weekend
With 13,000+ attendees and 500+ LPs expected in Helsinki, Slush 2026 remains the gravity center of European venture deal-making.
-
BDC Capital's $150M Life Sciences Fund: Canada's Medtech Layer Gets Capital
BDC Capital's life sciences venture fund bolsters Canadian therapeutics and medtech — an underrated pipeline for U.S. and EU follow-on rounds.